Portfolio company
Maculaser
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
The company develops temperature-controlled laser therapy devices for ophthalmologists to treat retinal disorders such as age-related macular degeneration and diabetic macular oedema.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Norlase
This company develops portable ophthalmic laser systems for retinal and glaucoma care, serving ophthalmologists and medical clinics worldwide.
Valon Lasers
This company manufactures multispot photocoagulation laser systems used by ophthalmologists to treat retinal diseases.
Macuject
This company develops artificial intelligence software that analyses macular scans to assist clinicians and pharmaceutical organisations in treating retinal diseases.
Oxular
Oxular develops drug delivery devices and sustained-release therapeutics for treating retinal diseases in patients with vision disorders.
oculex-pharmaceuticals
This company develops biodegradable intraocular implants and drug delivery systems to treat retinal diseases for patients with conditions such as macular oedema.
MgShell
MgShell develops biodegradable, magnesium-based intraocular drug delivery devices for patients suffering from retinal diseases such as maculopathy.
Deepeye Medical
This company develops artificial intelligence software that analyses eye scans to provide therapy planning support for ophthalmologists treating retinal diseases.
PulseMedica Corp.
This company develops an imaging and laser platform to screen and treat vitreoretinal diseases for patients with conditions like eye floaters.
